The process of blood formation is sustained throughout an individual's
life by a small population of haemopoietic stem cells (HSCs). The HSC
compartment represents a hierarchy of HSC subsets with decreasing pro
liferative ability. This heterogeneity is reflected in the varying tim
e periods that HSCs may contribute to the initiation and maintenance o
f donor-type haemopoietic multilineage chimerism in vivo. The phenotyp
e of HSC is incompletely defined rendering morphological or flow cytom
etric quantitation unreliable. Functional HSC assays, both in vitro (C
AFC, LTC-IC) and in vivo (repopulation of NOD/SCID mice) may be superi
or to phenotypic analysis; however, such assays have not been truly va
lidated in a human transplant setting. The quiescence and proliferatio
n of HSCs is highly regulated by the stroma in haemopoietic organs. Ma
ny of the cytokines that have been cloned in recent years are actually
elaborated and presented by the haemopoietic organ stroma and are sup
posed to serve as local regulators in order to gain specificity and av
oid pleitropic and thus undesired side effects. Most probably, additio
nal stroma-derived factors will be characterized as suggested by the o
bservation that HSCs produce more progeny in stroma-contact than in it
s absence or in stroma-conditioned medium, irrespectively of the exoge
nous cytokines included. Stem cells are considered to possess the abil
ity to self-renew and are therefore attractive vehicles for gene thera
py. The same assumed characteristic fuels attempts to amplify their nu
mbers ex vivo, and is expected to enable more rapid haemopoietic recov
ery of conditioned recipients as well as enlarge HSC grafts of insuffi
cient size before actual transplantation.